|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.230 USD | +13.40% |
|
+14.02% | +25.52% |
| 07-14 | Ironwood Pharmaceuticals, Inc. Announces Management Changes | CI |
| 05-27 | Ironwood Says US FDA Approves Linzess Use in Children Aged Two Years and Older With Functional Constipation | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 696M | - | - | |||
| 322B | |||||
| 71.6B | |||||
| 9.79B | |||||
| 8.39B | |||||
| 4.3B |
Select your edition
All financial news and data tailored to specific country editions
